Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 3
1986 5
1987 4
1988 10
1989 9
1990 3
1991 2
1992 1
1993 1
1996 1
1997 2
1998 3
1999 1
2000 2
2002 2
2003 1
2004 2
2005 3
2006 1
2008 4
2009 3
2010 3
2011 8
2012 3
2013 3
2014 3
2015 3
2016 2
2017 1
2020 2
2021 1
2022 2
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for novopen
Your search for novofen retrieved no results
NovoPen Echo() insulin delivery device.
Hyllested-Winge J, Sparre T, Pedersen LK. Hyllested-Winge J, et al. Med Devices (Auckl). 2016 Jan 7;9:11-8. doi: 10.2147/MDER.S59229. eCollection 2016. Med Devices (Auckl). 2016. PMID: 26793007 Free PMC article. Review.
The portable and discreet nature of pen devices reduces the burden on the patient, facilitates adherence, and subsequently contributes to the improvement in glycemic control. NovoPen Echo() is one of the latest members of the NovoPen() family that has been specifica …
The portable and discreet nature of pen devices reduces the burden on the patient, facilitates adherence, and subsequently contributes to th …
A review of 20 years' experience with the NovoPen family of insulin injection devices.
Rex J, Jensen KH, Lawton SA. Rex J, et al. Clin Drug Investig. 2006;26(7):367-401. doi: 10.2165/00044011-200626070-00001. Clin Drug Investig. 2006. PMID: 17163272 Review.
NovoPen, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen family of injection devices in diabetes management. ...Publications were examined and underwent a selection process to …
NovoPen, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use …
A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitus.
Hyllested-Winge J, Jensen KH, Rex J. Hyllested-Winge J, et al. Clin Drug Investig. 2010;30(10):643-74. doi: 10.2165/11584360-000000000-00000. Clin Drug Investig. 2010. PMID: 20701399 Review.
NovoPen, the first insulin pen, was introduced in 1985. This review article is an update of a review paper published in 2006 on 20 years' use of the NovoPen family of insulin pens in the management of diabetes mellitus. ...Most patients preferred the various Novo …
NovoPen, the first insulin pen, was introduced in 1985. This review article is an update of a review paper published in 2006 on 20 ye …
Novopen Echo for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionals.
Olsen BS, Lilleøre SK, Korsholm CN, Kracht T. Olsen BS, et al. J Diabetes Sci Technol. 2010 Nov 1;4(6):1468-75. doi: 10.1177/193229681000400622. J Diabetes Sci Technol. 2010. PMID: 21129343 Free PMC article. Clinical Trial.
This study assessed the usability, functionality and attitudes towards NovoPen Echo, a new durable insulin pen designed for pediatric patients that combines a simple memory function with half-increment dosing, versus NovoPen Junior and HumaPen Luxura HD in pediatric …
This study assessed the usability, functionality and attitudes towards NovoPen Echo, a new durable insulin pen designed for pediatric …
Novopen--a useful aid also for blind diabetic patients.
Sommerfeldt E, Oygard R, Sander J, Jervell J. Sommerfeldt E, et al. Diabetes Care. 1989 Apr;12(4):306-7. doi: 10.2337/diacare.12.4.306b. Diabetes Care. 1989. PMID: 2651057 No abstract available.
Comparison of preference for NovoPen() 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study.
Israël-Bultman H, Hyllested-Winge J, Kolaczynski M, Steindorf J, Garon J. Israël-Bultman H, et al. Clin Ther. 2011 Mar;33(3):346-57. doi: 10.1016/j.clinthera.2011.04.001. Clin Ther. 2011. PMID: 21600387

A total of 83.8% rated NovoPen 4 easier to use overall (P < 0.0001). Health care professionals (97.2%) would recommend NovoPen 4 to other patients. ...CONCLUSIONS: Patients reported a significant preference for NovoPen 4 compared with previous treatment wi

…

A total of 83.8% rated NovoPen 4 easier to use overall (P < 0.0001). Health care professionals (97.2%) would recommend NovoPen

…
Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.
Kadiri A, Chraibi A, Marouan F, Ababou MR, el Guermai N, Wadjinny A, Kerfati A, Douiri M, Bensouda JD, Belkhadir J, Arvanitis Y. Kadiri A, et al. Diabetes Res Clin Pract. 1998 Jul;41(1):15-23. doi: 10.1016/s0168-8227(98)00055-2. Diabetes Res Clin Pract. 1998. PMID: 9768368 Clinical Trial.
All patients used each insulin administration system for 12 weeks. Group A started therapy using NovoPen 3 and crossed over to syringe/vial administration; Group B started with syringe/vial administration followed by NovoPen 3. ...Acceptance of insulin injections wa …
All patients used each insulin administration system for 12 weeks. Group A started therapy using NovoPen 3 and crossed over to syring …
Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen.
Adolfsson P, Hartvig NV, Kaas A, Møller JB, Hellman J. Adolfsson P, et al. Diabetes Technol Ther. 2020 Oct;22(10):709-718. doi: 10.1089/dia.2019.0411. Epub 2020 Mar 11. Diabetes Technol Ther. 2020. PMID: 32003590 Free PMC article.
Background: This observational study investigated whether the connected NovoPen() 6 could influence insulin regimen management and glycemic control in people with type 1 diabetes (T1D) using a basal-bolus insulin regimen and continuous glucose monitoring in a real-world se …
Background: This observational study investigated whether the connected NovoPen() 6 could influence insulin regimen management and gl …
Clinical experience with NovoPen II and insulin Protaphane HM Penfill.
Kølendorf K, Beck-Nielsen H, Oxenbøll B. Kølendorf K, et al. Postgrad Med J. 1988;64 Suppl 3:14-6; discussion 21. Postgrad Med J. 1988. PMID: 3074294 Clinical Trial.
The acceptance of a new pen device, NovoPen II, was tested in 56 insulin-dependent diabetes mellitus patients. Fifty-two out of 55 patients who completed a questionnaire preferred to continue with NovoPen II and 51 found it easy to preselect the dose. In conclusion, …
The acceptance of a new pen device, NovoPen II, was tested in 56 insulin-dependent diabetes mellitus patients. Fifty-two out of 55 pa …
A comparison of injection force and dosage scale size between NovoPen 3 and NovoPen 4.
Donsmark M, Herold L, Kristensen CM. Donsmark M, et al. Diabetes Technol Ther. 2009 Sep;11(9):581-5. doi: 10.1089/dia.2008.0142. Diabetes Technol Ther. 2009. PMID: 19764837

The mean dosage scale digit size was 1.63 mm(2) for NovoPen 3 and 7.82 mm(2) for NovoPen 4, with a mean difference of 6.19 mm(2). The display for NovoPen 4 was 4.74 times larger (P < 0.001). CONCLUSIONS: The mean injection force required to operate Novo

…
The mean dosage scale digit size was 1.63 mm(2) for NovoPen 3 and 7.82 mm(2) for NovoPen 4, with a mean difference of 6.19 mm( …
93 results